Illumina Inks Co-Marketing Pacts with Caliper, Sage Science for Next-Gen Sequencing Sample Prep | GenomeWeb

Illumina said today that it has inked separate co-marketing agreements with Caliper Life Sciences and Sage Science to promote use of those companies' sample prep systems in next-generation sequencing applications.

Under the first agreement, Illumina will promote Caliper's LabChip XT, a preparative microfluidic platform for separating DNA fragments of different sizes that uses multi-channel disposable chips to run up to four samples in less than 30 minutes. Caliper said that the platform was developed "with direct input" from Illumina.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.